Table 4.

Comparison of AMH and vitamin D levels to VDR polymorphism in the PCOS and control groups

SNP	AMH (ng/mL) (median [IQR]/mean (SD))		25(OH)D [ng/mL] (median [IQR]/mean (SD))
	PCOS	Control	PCOS	Control
AMH rs10407022
GG	8.86 (6.02)	3.75 [1.92, 4.40]	17.00 [13.00, 26.77]	25.38 (14.82)
TG	9.47 (4.98)	3.60 [2.15, 5.97]	13.80 [11.20, 17.62]	19.31 (6.99)
TT	8.70 (6.53)	6.80 [2.90, 8.35]	12.90 [10.20, 19.10]	22.26 (7.53)
p value	0.869	0.685	0.112	0.527
AMHR2 rs2002555
AA	8.00 [4.68, 13.38]	4.40 [2.90, 9.20]	14.65 [11.62, 20.57]	19.20 [16.60, 27.10]
AG	10.00 [3.77, 12.45]	2.00 [1.10, 2.60]	13.50 [11.38, 15.72]	19.60 [15.80, 27.40]
GG	10.10 [8.40, 13.40]	4.90 [4.90, 4.90]	14.30 [12.70, 19.50]	27.40 [27.40, 27.40]
p value	0.724	0.260	0.742	0.618
Fok1 rs2228570
CC	7.60 [3.98, 11.95]	2.90 [0.90, 4.90]	14.10 [11.35, 19.67]	25.10 [17.90, 27.40]
CT	8.40 [4.70, 13.00]	4.90 [4.30, 7.30]	13.70 [11.70, 17.20]	16.60 [13.70, 19.60]
TT	14.10 [13.65, 18.60]	1.10 [1.10, 1.10]	17.00 [15.23, 18.62]	19.60 [19.60, 19.60]
p value	0.029	0.191	0.753	0.618
Apa1 rs7975232
AA	6.60 [3.60, 11.00]	3.70 [2.00, 4.90]	16.60 [12.90, 28.20]	19.20 [16.60, 27.10]
CA	10.50 [5.70, 13.80]	4.40 [3.80, 9.20]	11.90 [11.10, 15.75]	19.60 [15.80, 27.40]
CC	11.50 [10.60, 12.85]	0.80 [0.80, 0.80]	11.90 [11.85, 12.25]	11.30 [11.30, 11.30]
p value	0.028	0.254	0.013	0.317
Cdx2 rs11568820
A	4.80 [3.45, 6.60]	2.60 [2.60, 2.60]	14.90 [12.25, 24.35]	25.10 [25.10, 25.10]
A	10.20 [6.75, 13.85]	6.10 [3.20, 9.73]	11.75 [10.95, 17.25]	19.40 [17.38, 27.02]
GG	9.25 [4.36, 13.38]	3.35 [1.33, 4.40]	4.40 [11.78, 19.67]	18.10 [13.25, 27.40]
p value	0.076	0.220	0.543	0.890
Bsm1 rs1544410
AA	7.50 [3.08, 12.78]	3.30 [2.82, 5.45]	12.20 [11.07, 16.52]	19.30 [13.10, 25.58]
GA	8.70 [4.88, 13.95]	4.40 [4.05, 9.30]	14.10 [11.20, 18.90]	19.60 [18.45, 30.00]
GG	8.30 [4.65, 12.80]	1.85 [1.03, 5.38]	14.80 [11.85, 24.40]	16.65 [12.65, 27.18]
p value	0.755	0.288	0.374	0.349

*The results in italics are statistically significant